Identifying the genetic basis of variably protease-sensitive prionopathy

Broad Institute, Inc., Cambridge MA

Investigators

Linked publications & trials

Abstract

PROJECT SUMMARY First characterized one decade ago, VPSPr is a rare neurodegenerative disease that presents clinically as Lewy body dementia or frontotemporal lobar degeneration but has been neuropathologically linked to deposits of infectious but protease-sensitive prion protein (PrP) aggregates. VPSPr cases lack mutations in the prion protein gene (PRNP) but 42% of cases have a positive family history, consistent with a genetic disease of moderate penetrance. We will apply whole exome sequencing and deep targeted sequencing to query the genetic basis of VPSPr. Identification of a genetic cause of VPSPr will aid in the differential diagnosis of prion disease and Alzheimer’s-related dementias, validate new genomic technologies for understanding neurodegeneration, and identify new cellular pathways that lead to neurodegenerative disease.